Emily Leproust sells multiple TWST shares (NASDAQ: TWST)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Twist Bioscience (issuer) reported insider dispositions by Emily M. Leproust of Common stock on multiple dates. Transactions listed: 5,001 shares on 02/03/2026, 7,205 shares on 02/23/2026, 2,423 shares on 03/06/2026, 1,742 shares on 03/20/2026, and 1,610 shares on 04/21/2026. The filing also shows 8,061 shares described under "Securities To Be Sold" with an option grant date of 09/29/2017.
Positive
- None.
Negative
- None.
Key Figures
Sale on 02/03/2026: 5,001 shares
Sale on 02/23/2026: 7,205 shares
Sale on 03/06/2026: 2,423 shares
+3 more
6 metrics
Sale on 02/03/2026
5,001 shares
Disposition by Emily M. Leproust
Sale on 02/23/2026
7,205 shares
Disposition by Emily M. Leproust
Sale on 03/06/2026
2,423 shares
Disposition by Emily M. Leproust
Sale on 03/20/2026
1,742 shares
Disposition by Emily M. Leproust
Sale on 04/21/2026
1,610 shares
Disposition by Emily M. Leproust
Securities to be sold entry
8,061 shares
Listed 04/22/2026 with option grant date 09/29/2017
Key Terms
Form 144, Securities To Be Sold, Disposition for cash, Option Granted
4 terms
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Securities To Be Sold regulatory
"Common | 04/22/2026 | Option Granted - 09/29/2017"
Disposition for cash financial
"04/22/2026 | Cash"
Option Granted financial
"Option Granted - 09/29/2017"
FAQ
What did the Form 144 for TWST disclose?
It discloses multiple insider sales by Emily M. Leproust. The filing lists five open‑market dispositions dated 02/03/2026, 02/23/2026, 03/06/2026, 03/20/2026, and 04/21/2026 with the share counts and cash amounts shown per sale.
Does the Form 144 state who received the cash from the sales?
The filing lists the transactions as dispositions by the reporting person. The rows show cash proceeds per sale; the filing does not allocate proceeds beyond the seller entries shown in the excerpt.
Are these transactions reported as open‑market sales or another method?
The sales in the excerpt are shown with cash amounts, indicating dispositions for cash. The "Securities To Be Sold" line references an option and cash; specific distribution methods beyond that wording are not detailed in the excerpt.